Innoviva (NASDAQ:INVA) versus Roche (OTCMKTS:RHHBY) Head to Head Review
Innoviva (NASDAQ:INVA – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the superior investment? We will...
Head-To-Head Contrast: Avient (NYSE:AVNT) & ASP Isotopes (NASDAQ:ASPI)
Avient (NYSE:AVNT – Get Free Report) and ASP Isotopes (NASDAQ:ASPI – Get Free Report) are both basic materials companies, but which is the superior business?...
Intellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $60.00 by Analysts at Chardan Capital
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) had its price objective decreased by equities research analysts at Chardan Capital from $68.00 to $60.00 in a...
Lyft’s (LYFT) Neutral Rating Reaffirmed at Susquehanna
Lyft (NASDAQ:LYFT – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at Susquehanna in a note issued to investors on Monday,...
Innoviva (NASDAQ:INVA) Now Covered by Analysts at Oppenheimer
Stock analysts at Oppenheimer began coverage on shares of Innoviva (NASDAQ:INVA – Get Free Report) in a research report issued to clients and investors on...
Jefferies Financial Group Has Lowered Expectations for MarketAxess (NASDAQ:MKTX) Stock Price
MarketAxess (NASDAQ:MKTX – Get Free Report) had its price objective reduced by equities researchers at Jefferies Financial Group from $217.00 to $208.00 in a report...